A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients
Clinical trial NCT05753007 · TERMINATED
Trial details
- NCT number
- NCT05753007
- Sponsor
- Mclean Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2025-02-11
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.